Is Moderna’s (MRNA) Recent Rally a Sign of an Incoming Short Squeeze?

Moderna’s stock has been rallying recently, and it’s hard not to wonder if we’re seeing the early stages of a short squeeze. With a short interest rate sitting at 11.17% (as of Jan 15, 2025) and today’s positive price movement fueled by catalysts like the $500M+ Stargate Project announcement and the bird flu vaccine funding, it seems like shorts may soon be under pressure.

Here’s why a short squeeze might be on the horizon:

• High Short Interest: With over 43M shares shorted, the potential for forced buying is huge if the stock continues to climb.
• Strong Catalysts: Moderna is benefiting from a wave of optimism thanks to AI-driven vaccine development, the bird flu pandemic concerns, and renewed public support for vaccines following RFK Jr.’s recent comments.
• Momentum Build-Up: If the stock pushes past $50, we could see a break toward $60 or even $70 as shorts rush to cover.

For those watching closely, keep an eye on trading volume. A sharp spike could indicate that shorts are starting to cover their positions, which would further accelerate the price climb.

Could this rally push Moderna back to triple digits? Or is this just another false start? Would love to hear everyone’s thoughts!